iShares Barclays 20+ Yr Treas.Bond (NYSEARCA:TLT) Trades Flat

Posted by Lynn Eisler October 11, 2013 0 Comment 719 views


Everyone is talking about bonds nowadays and not because they are bullish. Interest rates are on the rise and the U.S Treasury default looms on the horizon. This makes fixed investments seem like a better option. However, all bonds cannot be bunched-up under a single category and the truth is that most of them are very different from each other. And so, if someone is discussing the bond market , the first question that should strike your mind is – which market? And which bond?

For a large part, there has been a plateauing in United States fixed income and long-term treasuries like iShares Barclays 20+ Yr Treas.Bond (NYSEARCA:TLT) have taken a major hit over the last one year.(250 days). Possibly, the one exception is U.S junk-bonds. These have managed to skirt the trend and dispensed a 4.8% advance over the last 250 trading-days right through 8 October.

Thursday’s trading

In Thursday’s trading, iShares Barclays 20+ Yr Treas.Bond (NYSEARCA:TLT) rose by 0.18%. The opening price of the shares was $104.82, which climbed to an intraday high of $105.53 and dipped to a close of $105.51. Approximately 9.94 million shares were traded on Thursday while an average volume of 8.21 million shares were traded over a 30 day period. The 52-week low of iShares Barclays 20+ Yr Treas.Bond (NYSEARCA:TLT) shares is $102.11 and its 52-week high is $127.19. The company has a market capitalization of $00.00 billion.

About the company

iShares Barclays 20+ Yr Treas.Bond (NYSEARCA:TLT) is an exchange traded fund. It seeks to track investment results of an index that is composed of U.S Treasury bonds that have remaining maturities that are more than 20 years. It seeks to track investment results of Barclays U.S. 20+ Year Treasury-Bond Index. This measures performance of public-obligations of the U.S Treasury that have a remainder maturity of 20+ years.



About Lynn Eisler

Lynn Eisler is a national news reporter focusing on economic issues, data analysis and the financial health of state and local governments. Lynn has been honored with the H.L. Mencken Award for Investigative Reporting, the Champion of Justice Award for reporting on the drug war, and the John Hancock Award for business reporting. Lynn was also a Knight Medical School Fellow at the University of Michigan.

View all post by Lynn Eisler Visit author's website

Write Your Comment